# ASPRUZYO SPRINKLE
> **NDA216018** · New Drug Application · Sponsor: SPIL · Approved 2022-02-28
## Drug
- **FDA Application Number:** NDA216018
- **Application type:** New Drug Application
- **Brand name:** ASPRUZYO SPRINKLE
- **Generic name:** RANOLAZINE
- **Active ingredients:** RANOLAZINE
- **Dosage form:** GRANULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SPIL
- **Manufacturer:** SUN PHARMACEUTICAL INDUSTRIES, INC.
- **First approval:** 2022-02-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216018)
---
*AI Analytics · CC0 1.0*